Biorce is launching Aika 2.0 at ASCO 2026 with a citywide live-demo ride experience, introducing the first AI-powered end-to-end operating system for clinical development.

Chicago, United States - [May 29, 2026] - Biorce, the AI-native clinical development company that raised $60M+ in under 12 months, today announced the launch of Aika 2.0, the first complete operating system for clinical trials, at the ASCO Annual Meeting 2026. Rather than exhibiting through a traditional conference booth, Biorce is taking the demo to the streets: from May 29 through June 1, ASCO attendees in Chicago can book a private ride across the city and experience Aika 2.0 in action, live, inside the vehicle.

Rather than exhibiting through a traditional conference booth, Biorce is transforming the ASCO experience itself. From May 29 through June 1, selected ASCO attendees in Chicago will be able to book private rides across the city while experiencing live demonstrations of Aika 2.0 in action. “Clinical trials just got a faster ride,” said Pedro Coelho, founder and CEO of Biorce. “This is what the industry has been waiting for, an intelligent operating system that connects every clinical development decision in real time.”

Aika 2.0 enables sponsors and CROs to generate protocols, simulations, feasibility analyses, budgets, contracts, and regulatory documentation within minutes. Every output is connected, traceable, and continuously updated across the platform, reducing operational friction and accelerating study execution. The platform introduces a continuous intelligent layer across the entire clinical development lifecycle, focused on scientific rigor, automation, oversight, and audit readiness.

“We wanted people to experience Aika 2.0 differently, not as pitch, but as a working system capable of transforming how clinical trials are run” the company added.

More about Aika 2.0 here: biorce.com/aika-2.0.